The first three patients have been enrolled in the European HISTORIC-AF staged hybrid ablation study, Estech announced Monday afternoon. Ten centers will participate in the study, which is expected to enroll more than 100 persistent and long-standing persistent atrial fibrillation patients in Italy, Germany, the U.K., France and Poland. Estech release